- BioRN Network
- Cluster Management
About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant part in this development.
With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”
January 29, 2015
DKFZ: Activated immune cells indicate a favorable prognosis in colorectal cancer
January 28, 2015
Roche delivers solid results in 2014
January 23, 2015
Heidelberg Researchers Find Unusually Elastic Protein
Read our monthly BioRN Newsletter. It will keep you informed about what´s going on in the BioRN cluster.
» Find further future events here